Trials / Active Not Recruiting
Active Not RecruitingNCT04081220
Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2
An Investigator Initiated Phase 2 Trial of the LSD1 Inhibitor IMG-7289 in Essential Thrombocythemia (CTMS# 19-0078)
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-center, open-label investigator-initiated trial evaluating the effects of IMG-7289 administered orally once daily in patients with essential thrombocythemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IMG-7289 | Single starting dose with individualized dose titrations throughout |
Timeline
- Start date
- 2020-04-09
- Primary completion
- 2023-12-20
- Completion
- 2026-12-20
- First posted
- 2019-09-09
- Last updated
- 2025-09-10
- Results posted
- 2025-05-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04081220. Inclusion in this directory is not an endorsement.